Five-year survival rate

From WikiMD's WELLNESSPEDIA

Five-year survival rate is a term used in oncology to indicate the percentage of patients who live at least five years after their cancer is diagnosed. It is often used as a standard way of discussing a person's prognosis.

Overview[edit]

The five-year survival rate is a type of survival rate for estimating the prognosis of a particular disease, usually cancer. It is the percentage of patients who live at least five years after being diagnosed with the disease. For example, a five-year survival rate of 70% means that an estimated 70 out of 100 people who have the disease are alive five years after being diagnosed.

Calculation[edit]

The five-year survival rate is calculated from the time of diagnosis or start of treatment and includes all causes of death, not just the disease being studied. It does not mean that all patients will live for at least five years. Some may live much longer, while others may die sooner.

Factors affecting the five-year survival rate[edit]

The five-year survival rate can be influenced by many factors, including the type and stage of cancer, the patient's age and overall health, and the treatment received.

Limitations[edit]

While the five-year survival rate is a useful tool in estimating prognosis, it has its limitations. It does not take into account recent improvements in treatment, and it does not predict individual outcomes.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.